TISSUE Regenix’s replacement heart valve technology will be presented at a congress in Venice this week.
The business, based at York Science Park, has developed a patented technology which enables them to “wash” the DNA from pigs’ heart valves to provide a scaffold which can be used in human transplants.
Professor Francisco da Costa, the internationally renowned cardiac surgeon from Pontifical University of Parana, Brazil, will present his findings on the company’s technology at the seventh Biennial Congress of the Society for Heart Valve Disease & Heart Valve Society of America in Venice on Sunday.
Prof da Costa, who is a research partner of Tissue Regenix, said: “In our experience, the decellularised valves seem to be providing superior reconstruction in these patients.
“It has been very gratifying to see such excellent results.”
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here